Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
BMC Cancer|September 30, 2020
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancerMarkus Hecht, Dennis Hahn, Philipp Wolber, et al.Frontiers in Oncology|March 6, 2023
Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracyThomas Weissmann, Yixing Huang, Stefan Fischer, et al.Frontiers in Oncology|September 30, 2024
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral bloodAnna-Jasmina Donaubauer, Benjamin Frey, Manuel Weber, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trialRainer Fietkau, Markus Hecht, Benjamin Hofner, et al.Journal of Clinical Medicine|October 23, 2021
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring ApproachThomas Weissmann, Stefan Speer, Florian Putz, et al.Medcomm|January 16, 2026
Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaJian-Guo Zhou, Markus Eckstein, Haitao Wang, et al.Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.Pageof 13